SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.820
-0.130 (-6.67%)
At close: Feb 21, 2025, 4:00 PM
1.760
-0.060 (-3.30%)
After-hours: Feb 21, 2025, 4:57 PM EST
SAB Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 17 | 63 | 30 | 340 | - | - |
| Market Cap Growth | -24.40% | 113.36% | -91.24% | - | - | - |
| Enterprise Value | -9 | 66 | 27 | 336 | - | - |
| Last Close Price | 1.82 | 6.88 | 5.90 | 78.10 | - | - |
| PS Ratio | 10.38 | 28.33 | 1.24 | 5.58 | - | - |
| PB Ratio | 0.46 | 1.11 | 0.96 | 8.81 | - | - |
| P/TBV Ratio | 0.68 | 1.11 | 0.96 | 8.81 | - | - |
| P/OCF Ratio | - | - | - | 170.89 | - | - |
| EV/Sales Ratio | - | 29.32 | 1.14 | 5.51 | - | - |
| Debt / Equity Ratio | 0.12 | 0.10 | 0.19 | 0.22 | 0.21 | 0.99 |
| Debt / EBITDA Ratio | - | - | - | - | 0.38 | - |
| Asset Turnover | 0.04 | 0.03 | 0.36 | 0.88 | 1.48 | - |
| Quick Ratio | 3.46 | 5.23 | 1.37 | 1.56 | 3.00 | 1.98 |
| Current Ratio | 3.69 | 5.45 | 1.47 | 1.90 | 3.11 | 2.01 |
| Return on Equity (ROE) | -174.73% | -95.51% | -53.85% | -44.21% | 86.15% | - |
| Return on Assets (ROA) | -78.80% | -35.30% | -27.37% | -12.16% | 34.47% | - |
| Return on Capital (ROIC) | -105.52% | -47.50% | -43.01% | -17.77% | 41.14% | - |
| Return on Capital Employed (ROCE) | - | - | - | - | 45.20% | - |
| Earnings Yield | -271.28% | -66.52% | -63.04% | -5.05% | - | - |
| FCF Yield | -229.54% | -39.91% | -86.20% | -2.64% | - | - |
| Buyback Yield / Dilution | -74.13% | -26.86% | -59.20% | -1.21% | 23.30% | - |
| Total Shareholder Return | -74.13% | -26.86% | -59.20% | -1.21% | 23.30% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.